{"id":"https://openalex.org/W2114072789","doi":"https://doi.org/10.1046/j.1463-1326.2003.00297.x","title":"Greater reductions in A1C in type 2 diabetic patients new to therapy with glyburide/metformin tablets as compared to glyburide co\u2010administered with metformin","display_name":"Greater reductions in A1C in type 2 diabetic patients new to therapy with glyburide/metformin tablets as compared to glyburide co\u2010administered with metformin","alternate_titles":[],"publication_year":2003,"publication_date":"2003-11-01","ids":{"openalex":"https://openalex.org/W2114072789","doi":"https://doi.org/10.1046/j.1463-1326.2003.00297.x","mag":"2114072789","pmid":"https://pubmed.ncbi.nlm.nih.gov/14617228"},"language":"en","primary_location":{"id":"doi:10.1046/j.1463-1326.2003.00297.x","doi":"https://doi.org/10.1046/j.1463-1326.2003.00297.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1463-1326.2003.00297.x","pdf_url":null,"source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2114072789"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5070289715","display_name":"Lawrence Blonde","orcid":"https://orcid.org/0000-0003-0492-6698","observed_orcids":["https://orcid.org/0000-0003-0492-6698"]},"institutions":[{"id":"https://openalex.org/I2799767083","display_name":"Ochsner Medical Center","ror":"https://ror.org/0290qyp66","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1336053918","https://openalex.org/I2799767083"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"L. Blonde","raw_affiliation_strings":["Ochsner Clinic Foundation, New Orleans, LA 70121, USA. lblonde@ochsner.org","Ochsner Clinic Foundation, New Orleans, LA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ochsner Clinic Foundation, New Orleans, LA 70121, USA. lblonde@ochsner.org","institution_ids":["https://openalex.org/I2799767083"]},{"raw_affiliation_string":"Ochsner Clinic Foundation, New Orleans, LA, USA","institution_ids":["https://openalex.org/I2799767083"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028035210","display_name":"Jenifer Wogen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J. Wogen","raw_affiliation_strings":["The Institute for Effectiveness Research L.L.C., Bridgewater, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Institute for Effectiveness Research L.L.C., Bridgewater, NJ, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111973531","display_name":"Charles Kreilick","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"C. Kreilick","raw_affiliation_strings":["The Institute for Effectiveness Research L.L.C., Bridgewater, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Institute for Effectiveness Research L.L.C., Bridgewater, NJ, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5052357305","display_name":"Andrea Ann Seymour","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A. A. Seymour","raw_affiliation_strings":["Bristol-Myers Squibb, Plainsboro, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Plainsboro, NJ, USA","institution_ids":["https://openalex.org/I4210091812"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5070289715"],"corresponding_institution_ids":["https://openalex.org/I2799767083"],"apc_list":{"value":5380,"currency":"USD","value_usd":5380},"apc_paid":null,"fwci":1.3448,"has_fulltext":false,"cited_by_count":72,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.80924189,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"5","issue":"6","first_page":"424","last_page":"431"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9319999814033508},{"id":"https://openalex.org/keywords/glibenclamide","display_name":"glibenclamide","score":0.8830000162124634},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":1.0},{"id":"https://openalex.org/keywords/fixed-dose-combination-tablets","display_name":"fixed-dose combination tablets","score":0.9089999794960022},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.8579999804496765},{"id":"https://openalex.org/keywords/hba1c-reduction","display_name":"HbA1c reduction","score":0.8320000171661377},{"id":"https://openalex.org/keywords/combination-antidiabetic-therapy","display_name":"combination antidiabetic therapy","score":0.8510000109672546},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.7879999876022339},{"id":"https://openalex.org/keywords/usual-care","display_name":"usual care","score":0.5820000171661377},{"id":"https://openalex.org/keywords/drug-formulation-comparison","display_name":"drug formulation comparison","score":0.3720000088214874},{"id":"https://openalex.org/keywords/dose-adjustment","display_name":"dose adjustment","score":0.3700000047683716},{"id":"https://openalex.org/keywords/baseline-hba1c","display_name":"baseline HbA1c","score":0.5569999814033508},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.3330000042915344}],"concepts":[{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.9839667081832886},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9253331422805786},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6263922452926636},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6100801229476929},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5774502158164978},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5327346920967102},{"id":"https://openalex.org/C2779768347","wikidata":"https://www.wikidata.org/wiki/Q420626","display_name":"Glibenclamide","level":3,"score":0.5020146369934082},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.43419933319091797},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3068588078022003}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005905","descriptor_name":"Glyburide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010349","descriptor_name":"Patient Compliance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012044","descriptor_name":"Regression Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013607","descriptor_name":"Tablets","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1046/j.1463-1326.2003.00297.x","doi":"https://doi.org/10.1046/j.1463-1326.2003.00297.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1463-1326.2003.00297.x","pdf_url":null,"source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},{"id":"pmid:14617228","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14617228","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, obesity & metabolism","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":24,"referenced_works":["https://openalex.org/W1966408965","https://openalex.org/W1975588287","https://openalex.org/W1995404454","https://openalex.org/W1998420557","https://openalex.org/W1999398484","https://openalex.org/W2036939737","https://openalex.org/W2047511891","https://openalex.org/W2059649085","https://openalex.org/W2066929611","https://openalex.org/W2090001313","https://openalex.org/W2114102308","https://openalex.org/W2117858992","https://openalex.org/W2118597037","https://openalex.org/W2123946565","https://openalex.org/W2125914635","https://openalex.org/W2136225651","https://openalex.org/W2151921086","https://openalex.org/W2164789983","https://openalex.org/W2166640752","https://openalex.org/W2169735327","https://openalex.org/W2188846692","https://openalex.org/W2322161716","https://openalex.org/W2324992560","https://openalex.org/W2337454357"],"related_works":["https://openalex.org/W2079229392","https://openalex.org/W2003474285","https://openalex.org/W2096999369","https://openalex.org/W1995404454","https://openalex.org/W2082917156","https://openalex.org/W2151921086","https://openalex.org/W132968848","https://openalex.org/W1999398484","https://openalex.org/W2592885935","https://openalex.org/W2032299282"],"abstract_inverted_index":{"BACKGROUND:":[0],"A":[1],"cohort":[2,59,139],"of":[3,107,141,173,216,230,254,326],"patients":[4,21,38,143,156,177,238,265,353],"with":[5,25,43,50,83,89,132,153,181,235,239,262,266,294,306,350,354],"type":[6,35,355],"2":[7,36,356],"diabetes,":[8,357],"prescribed":[9],"glyburide/metformin":[10,45,84,146,219,289,307,337],"tablets,":[11],"experienced":[12,244],"significantly":[13,222,246,341],"greater":[14,226,250,342],"improvements":[15],"in":[16,32,52,115,252,283,328,344,352],"glycaemic":[17],"control":[18],"compared":[19,256],"to":[20,40,79,122,257],"receiving":[22],"glyburide":[23,48,87,151,179,233,260,292,348],"co-administered":[24,49,88,152,180,234,261,293,349],"metformin.":[26,154,236,263],"AIM:":[27],"To":[28],"compare":[29],"the":[30,71,228,271,274,281],"change":[31,112,327],"A1C":[33,99,116,128,213,241,253,268,275,284,345,361],"for":[34,124,211,218,232,259,287],"diabetic":[37],"new":[39,78],"combination":[41,81,109],"therapy":[42,82,133],"fixed-dose":[44],"tablets":[46,85,147,220,290,308,338],"vs.":[47,163,189,198,310],"metformin":[51,90,182,195,295,351],"a":[53,245,323,340],"usual-care":[54],"setting.":[55],"METHODS:":[56],"This":[57],"retrospective":[58],"study":[60],"analysed":[61,118],"medication":[62,333],"usage":[63],"via":[64],"an":[65],"administrative":[66],"pharmacy":[67],"claims":[68],"database":[69],"and":[70,94,97,103,129,148,169,214,291,297],"patients'":[72],"corresponding":[73],"laboratory":[74],"results.":[75],"Patients":[76,302],"were":[77,157,285,303],"antidiabetic":[80],"or":[86],"between":[91,273],"August":[92],"2000":[93],"July":[95],"2001":[96],"had":[98],"measurements":[100],"at":[101],"baseline":[102,114,208,212,240,267,360],"within":[104],"76-194":[105],"days":[106],"initiating":[108],"therapy.":[110],"The":[111,138,204,331],"from":[113,207],"was":[117,134,221,321],"using":[119],"statistical":[120],"regression":[121,316],"adjust":[123],"significant":[125,324],"covariates":[126],"(baseline":[127],"dosage).":[130],"Adherence":[131],"also":[135],"compared.":[136],"RESULTS:":[137],"consisted":[140],"950":[142],"who":[144],"received":[145,170],"471":[149],"taking":[150,178],"Glyburide/metformin":[155,237],"younger":[158],"(mean":[159],"age":[160],"=":[161,187,196,300],"56":[162],"60":[164],"years,":[165],"p":[166,192,201,299,312],"<":[167,193,202,224,248,269,313],"0.0001)":[168,225,249],"lower":[171,332],"doses":[172,334],"each":[174],"drug":[175],"than":[176,227,346],"(glyburide":[183],"mean":[184,205],"final":[185],"dose":[186],"6":[188],"10":[190],"mg/day,":[191,200],"0.0001;":[194],"893":[197],"1297":[199],"0.0001).":[203],"decrease":[206,229,251],"A1C,":[209],"adjusted":[210],"dosage,":[215],"2.02%":[217],"(p":[223,247],"1.49%":[231],">/=":[242,362],"8":[243],"2.93%":[255],"1.92%":[258],"For":[264],"8%,":[270],"difference":[272],"responses":[276],"remained":[277],"significant,":[278],"even":[279],"though":[280,315],"reductions":[282],"smaller":[286],"both":[288],"(0.54%":[296],"0.23%,":[298],"0.0017).":[301],"more":[304],"adherent":[305],"(84%":[309],"76%,":[311],"0.0001),":[314],"analysis":[317],"indicated":[318],"that":[319],"adherence":[320],"not":[322],"predictor":[325],"A1C.":[329],"CONCLUSIONS:":[330],"delivered":[335],"by":[336],"provided":[339],"reduction":[343],"did":[347],"especially":[358],"when":[359],"8%.":[363]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2114072789","counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
